● Recruiting

Multicenter Cohort Study of ESD and Chemo-radiotherapy for High-risk Early-stage Esophageal Cancer

Condition: Esophagus Cancer · Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

PhaseN/A

Planned participants120

Who can joinAll sexes, 18 Years to 75 Years

Healthy volunteersNo

About this study

This multicenter, prospective observational cohort study has the potential to optimize individualized chemoradiotherapy regimen for early-stage esophageal cancer patients who have received endoscopic submucosal dissection.

This description comes directly from the study's public registry record.

Talk to the study team

Jing Xu, MD · 0086-0571-87783521 · jing_xu@zju.edu.cn

Qichun Wei, PHD · 0086-0571-87783521 · qichun_wei@zju.edu.cn

Always discuss trial participation with your own doctor first.

Locations (2)

The Second Affiliated Hospital of Zhejiang University School of Medicine	Hangzhou, Zhejiang, China	Recruiting
The Second Affiliated Hospital of Zhejiang University, School of Medicine	Hangzhou, China	Not Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06385717